Use Nektar Therapeutics story together with your assets to protect against small markets fluctuations as well as to check it against diversification policy that fits your risk preferences.
This story from stocks.us.reuters.com contributed to next trading day price increase. The story delta to the next closing price was 6.33% . The story delta to the current price is 22.09% .
Sacramento Bee - Apr 10, 2012
By Nektar Therapeutics SAN FRANCISCO, April 10, 2012 -- /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) will host an Investor and Analyst R&D Day for its institutional investors and research analysts on Monday, April 16, 2012 from 12:00 pm to 5:00 ...
pharmabiz.com - Apr 4, 2012
Nektar Therapeutics, a biopharmaceutical company developing novel therapeutics based on its PEGylation and advanced polymer conjugation technology platforms, has dosed first subject in a phase I clinical study to evaluate the pharmacokinetics and ...
Nektar Doses First Subjects in Phase 1 Clinical Study Evaluating NKTR-192, a ... - PR Newswire (press release)
RTT News - Mar 28, 2012
(RTTNews) - Nektar Therapeutics (NKTR: News ) reported that its partner Affymax, Inc. announced that the US Food and Drug Administration, or FDA, has approved OMONTYS (peginesatide) injection for the treatment of anemia due to chronic kidney disease in ...
Nektar Therapeutics - NKTR - FDA Approval of OMONTYS - Fyxnews
Affymax, Takeda Win Approval of Anemia Drug to Challenge Amgen - Xconomy
Z-Score is a simple linear, multi-factor model that measures the financial health and economic stability of a company. The score is used to predict probability of a firm going into bankruptcy within next 24 months or two fiscal years from the day stated on the accounting statements used to calculate it. The model uses five fundamental business ratios that are weighted according to algorithm of Professor Edward Altman who developed it in late 1960s at New York University..
USA 
Equity Search
Advanced Search
Market Screener
Adviser Directory
Suggest Portfolio
Backtest Watchlist
Analyze Correlations
View Transactions
Check Volatility
Import Equities
Summary
Fundamentals
Technicals
Performance
Valuation
Volatility
History
News
Management
Discussion
